摘要
目的:分析Ⅱ期大肠癌(CRC)肿瘤部位与肿瘤标志CEA和CA199表达差异,探讨大肠癌临床病理及分子生物学因素与预后的相关性。方法:对近10年中山大学附属肿瘤医院217例临床Ⅱ期左右侧CRC术后患者进行回顾性分析。结果:左大肠癌89例(41.0%),右大肠癌128例(59.0%)。经χ2检验,左右侧大肠癌肿瘤标志CEA水平差异有统计学意义,P=0.029;年龄差异也有统计学意义,P=0.005。生存亚组分析结果显示,右侧大肠癌CA199阳性患者生存率低于阴性,P=0.160,而左侧则无统计学意义,P=0.256。独立预后因素为肿瘤部位、肿瘤大体和术后复发转移(HR分别为1.97、0.47和6.74)。结论:CEA、肿瘤部位、肿瘤大体和术后复发转移是独立预后因素;右侧大肠癌患者血清CA199阳性与预后差相关。
OBJECTIVE: To analyze the tumor marker CEA,CA199 expression in stage Ⅱ colorectal cancer(CRC) and to discuss the correlationship between the prognosis of CRC and its clinical pathology and molecular biological factors. METHODS: The clinical data of 217 patients during the past ten years in the affiliated oncology hospital of Sun Yat-sen University were analyzed retrospectively. RESULTS: The left colorectal cancer were 89 cases (41.0 %) and the right were 128 cases (59.0%). Between the left and right cases CEA and age had significantly differences (P=0. 029; P=0. 005). Subgroup Kaplan-Meier analyze of CA199 in the right location shown that the patients with a high level had a shorter OS than those with low. The independent prognostic factors were tumor location, tumor morphology, recurrence and metas- tasis (HR respectively were 1.97, 0.47 and 6.74). CONCLUSIONS: CEA is a prognostic factor on location, volume and relapse and metastsis between left and right colorectal cancer. In the right location the patients with a high level of CA199 have a shorter OS. Tumor site is an independent prognostic factor and it can be used as a reference of clinical medicine and treatment.
出处
《中华肿瘤防治杂志》
CAS
北大核心
2012年第15期1169-1172,共4页
Chinese Journal of Cancer Prevention and Treatment